Isolate no. | Ceftriaxone MICs (mg/L) | Antimicrobial characteristics | NG-MAST | PBP2 allele | Polymorphisms in: | |||||
---|---|---|---|---|---|---|---|---|---|---|
porB | tbpB | STs | MtrR | PorB1b | PBP1 | PilQ | ||||
NJ-1 | 0.25 | CMRNG, CipR# | 5658 | 111 | 9530* | XVIII | −57A del, A39T | G120K, A121D | L421P | wt |
NJ-2 | 0.25 | CMRNG, CipR | 5175 | 328 | 8737 | XVIII | −57A del, A39T | G120K, A121D | L421P | wt |
NJ-3 | 0.125 | PPNG, CipR | 5659 | 107 | 9531* | XVIII | −57A del | G120K, A121G | L421P | wt |
NJ-4 | 0.125 | PP/TRNG, CipR | 1053 | 186 | 3289 | XVIII | −57A del | G120K, A121D | L421P | wt |
NJ-5 | 0.125 | PPNG, CipR | 1854 | 33 | 9532* | XLI** | −57A del | G120N, A121D | L421P | wt |
NJ-6 | 0.125 | PP/TRNG, CipR | 543 | 294 | 9533* | XVIII | A39T | G120K, A121G | L421P | wt |
NJ-7 | 0.125 | CMRNG, CipR | 5660 | 186 | 9534* | XVIII | −57A del | G120K, A121G | L421P | wt |
NJ-8 | 0.125 | CMRNG, CipR | 505 | 135 | 2186 | XVIII | −57A del | G120K, A121D | L421P | wt |
NJ-9 | 0.125 | CMRNG, CipR | 1285 | 4 | 9535* | XIII | −57A del, G45D | G120K, A121D | L421P | wt |
NJ-10 | 0.125 | TRNG, CipR | 4 | 831 | 3746 | XIII | −57A del | G120K, A121D | L421P | wt |
NJ-11 | 0.125 | CMRNG, CipR | 3530 | 4 | 9536* | XVIII | −57A del | G120K, A121G | L421P | wt |
NJ-12 | 0.125 | CMRNG, CipR | 1198 | 156 | 2461 | XVIII | −57A del, A39T | G120K, A121G | L421P | wt |
NJ-13 | 0.125 | CMRNG, CipR | 5661 | 4 | 5061 | XVIII | −57A del, G45D | G120K, A121N | L421P | wt |
NJ-14 | 0.125 | CMRNG, CipR | 2978 | 1058 | 9537* | XII | −57A del | G120K, A121D | L421P | wt |
NJ-15 | 0.125 | TRNG, CipR | 543 | 438 | 9538* | XVIII | −57A del | G120K, A121G | L421P | wt |